References

  1. Boaitey YA, Nkrumah B, Idriss A, Kofi Tay SC. Gastrointestinal and urinary tract pathogenic infections among HIV seropositive patients at the Komfo Anokye teaching hospital in Ghana. BMC Res Notes. 2012; 5:454. PubMed | Google Scholar

  2. Guha D, Ayyavoo V. Innate immune evasion strategies by Human Immunodeficiency Virus type 1. ISRN AIDS. 2013; 2013:954806. PubMed | Google Scholar

  3. Adeyemi AI, Sulaiman AA, Solomon BB, Chinedu OA, Victor IA. Bacterial bloodstream infections in HIV-infected adults attending a Lagos teaching hospital. J Health Popul Nutr. 2010; 28(4):318-326. PubMed | Google Scholar

  4. Mofenson LM, Brady MT, Danner SP, Dominguez KL, Hazra R, Handelsman E, Havens P, Nesheim S, Read JS, Serchuck L, Van Dyke R, Centers for Disease Control and Prevention, National Institutes of Health, HIV Medicine Association of the Infectious Diseases Society of America, Pediatric Infectious Diseases Society; American Academy of Pediatrics. Guidelines for the Prevention and Treatment of Opportunistic Infections Among HIV-Exposed and HIV-Infected Children: Recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics. MMWR Recomm Rep. 2009; 58(RR-11): 1. PubMed | Google Scholar

  5. Seddon J, Bhagani S. Antimicrobial therapy for the treatment of opportunistic infections in HIV/AIDS patients: a critical appraisal. HIV AIDS-Res Pal Care. 2011; 3: 19-33. PubMed | Google Scholar

  6. Cotton MF, Wasserman E, Smit J, Whitelaw A, Zar HJ. High incidence of antimicrobial resistant organisms including extended spectrum beta-lactamase producing Enterobacteriaceae and methicillin-resistant Staphylococcus aureus in nasopharyngeal and blood isolates of HIV-infected children from Cape Town, South Africa. BMC Infect Dis. 2008; 8: 40. PubMed | Google Scholar

  7. Mwansa J, Mutela K, Zulu I, Amadi B, Kelly P. Antimicrobial sensitivity in enterobacteria from AIDS patients, Zambia. Emerg Infect Dis. 2002; 8(5): 540. PubMed | Google Scholar

  8. NCCLS. Performance Standards for antimicrobial susceptibility testing, fourteenth informational supplement. NCCLS document M100-S14, Villanova, PA: NCCLS. 2004. PubMed | Google Scholar

  9. Okeke IN. Diarrheagenic Escherichia coli in sub-saharan Africa: status, uncertainties and necessities. J Infect Dev Ctries. 2009;3(11):817-842. PubMed | Google Scholar

  10. Cohen MB, Nataro JP, Bernstein DI, Hawkins J, Roberts N, Staat MA. Prevalence of diarrheagenic Escherichia coli in acute childhood enteritis: a prospective controlled study. J Pediatr. 2005;146(1):54-61. PubMed | Google Scholar

  11. Gassama-Sow A, Sow PS, Guèye M, Guèye-N'diaye A, Perret JL, M'boup S, Aïdara-Kane A. Characterization of pathogenic Escherichia coli in human immunodeficiency virus-related diarrhea in Senegal. J Infect Dis. 2004; 189(1):75-78. PubMed | Google Scholar

  12. Abong'o BO, Momba MN, Malakate VK, Mwambakana JN. Prevalence of Escherichia coli O157:H7 among diarrhoeic HIV/AIDS patients in the Eastern Cape Province-South Africa. Pak J Biol Sci. 2008;11(8):1066-75. PubMed | Google Scholar

  13. Ronald A. The etiology of urinary tract infection: traditional and emerging pathogens. Am J Med. 2002; 113 (1A):14S-19S. PubMed | Google Scholar

  14. Vignesh R, Shankar EM, Murugavel KG, Kumarasamy N, Sekar R, Irene P, Solomon S, Balakrishnan P. Urinary infections due to multi-drug-resistant Escherichia coli among persons with HIV disease at a tertiary AIDS care centre in South India. Nephron Clin Pract. 2008;110(1):c55-c57. PubMed | Google Scholar

  15. Minta DK, Dembele M, Diarra AS, Sidibe AT, Cisse IA, Aldiouma H, Fongoro S, Maiga II, Pichard E, Traore HA. Association of urinary tract infections and HIV infection in an internal medicine ward of Hospital of Point G-Bamako-Mali. Mali Med. 2007;22(2):23-27. PubMed | Google Scholar

  16. Byam PR, Pierre RB, Christie CD, Andiman WA, Pettigrew M. Kingston Paediatric and Perinatal HIV/AIDS (KPAIDS) Study Group. West Indian Med J. 2010; 59 (4):386-392. PubMed | Google Scholar

  17. Chiller TM, Polyak CS, Brooks JT, Williamson J, Ochieng B, Shi YP, Ouma P, Greene C, Hamel M, Vulule J, Bopp C, Slutsker L, Mintz E. Daily trimethoprim-sulfamethoxazole prophylaxis rapidly induces corresponding resistance among intestinal Escherichia coli of HIV-infected adults in Kenya. J Int Assoc Physicians AIDS Care. 2009;8(3):165-169. PubMed | Google Scholar

  18. Morpeth SC, Thielman NM, Ramadhani HO, Hamilton JD, Ostermann J, Kisenge PR, Shao HJ, Reller LB, Itemba DK, Sam NE, Bartlett JA, Shao JF, Crump JA. Effect of trimethoprim-sulfamethoxazole prophylaxis on antimicrobial resistance of fecal Escherichia coli in HIV-infected patients in Tanzania. J Acquir Immune Defic Syndr. 2008;47(5):585-591. PubMed | Google Scholar